![](/jdrfimpactreport2021/static/d166c11879efe632f609cb1b57d02f38/cf8e8/in-research-header.jpg)
In Research
JDRF Canada and its affiliate partners are leading the international research effort to end type 1 diabetes (T1D).
Here’s how we moved the needle in 2021:
36 cutting-edge projects and clinical trials supported in Canada
nearly $80 million CAD invested in T1D research worldwide
19 countries with active grants – demonstrating the scope of JDRF’s 2021 international research portfolio
50+ clinical trials supported in Canada and around the world to bring new treatments to market faster
60+ new research grants for the world’s most promising studies
275+ active projects
Previous Page
![](/jdrfimpactreport2021/static/2a988a0469ccf04df39da4a1121080dc/0006d/collective-impact-card.jpg)
Our Collective Impact: Overview
Next Page
![](/jdrfimpactreport2021/static/c68d7e4407550932ac5eb59fea35126b/d0ecf/through-advocacy-card.jpg)
Through Our Advocacy